Literature DB >> 9195161

Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.

A Valent1, G Danglot, A Bernheim.   

Abstract

trk (NTRK) genes encode tyrosine kinase transmembrane receptors that are stimulated by neurotrophins, and are responsible for the transduction of signals controlling neuropoiesis and neuron survival in the central and peripheral nervous system, trkA gene has earlier been assigned to three different loci on chromosome 1. To resolve these conflicting results, and confirm the localization of trkB and trkC, probes specific to each of these related genes were constructed and used in fluorescent in situ hybridization on human metaphase cells. Our results indicate that trkA, trkB and trkC are located in chromosome bands 1q22, 9q22 and 15q25, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195161

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.

Authors:  Xiang-Yang Lou; Guo-Bo Chen; Lei Yan; Jennie Z Ma; Jun Zhu; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2007-04-25       Impact factor: 11.025

Review 2.  TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Authors:  Shivaani Kummar; Ulrik N Lassen
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

3.  NTRK2 methylation is related to reduced PTSD risk in two African cohorts of trauma survivors.

Authors:  Vanja Vukojevic; David Coynel; Navid R Ghaffari; Virginie Freytag; Thomas Elbert; Iris-Tatjana Kolassa; Sarah Wilker; James L McGaugh; Andreas Papassotiropoulos; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

Review 4.  NTRK gene fusions as novel targets of cancer therapy across multiple tumour types.

Authors:  Alessio Amatu; Andrea Sartore-Bianchi; Salvatore Siena
Journal:  ESMO Open       Date:  2016-03-18

Review 5.  Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.

Authors:  A Amatu; A Sartore-Bianchi; K Bencardino; E G Pizzutilo; F Tosi; S Siena
Journal:  Ann Oncol       Date:  2019-11-01       Impact factor: 51.769

Review 6.  How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?

Authors:  Simon Ekman
Journal:  Transl Lung Cancer Res       Date:  2020-12

Review 7.  New Approaches with Precision Medicine in Adult Brain Tumors.

Authors:  Annette Leibetseder; Matthias Preusser; Anna Sophie Berghoff
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

Review 8.  NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.

Authors:  Fangfang Liu; Yuxuan Wei; Huan Zhang; Jizong Jiang; Peng Zhang; Qian Chu
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 9.  The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer.

Authors:  Haixia Qin; Manish R Patel
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

10.  Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia.

Authors:  Marina Mantzourani; George P Chrousos; Styliani A Geronikolou; Işil Takan; Athanasia Pavlopoulou
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.